Biography/Memoir

Oregon regulators grant first license to psilocybin edibles manufacturer

Regulators in Oregon have licensed the country’s first-ever state-legal psilocybin edibles manufacturer, the Southeast Portland company announced… The Milwaukie-based company’s brand… said in a press release… includes “dark chocolates precisely dosed with dried, homogenized mushrooms, have a chocolate-forward flavor with nutty and earthy notes from the mushrooms.” Original Article (Marijuana Moment):Oregon regulators grant first license…

READ MORE
Biography/Memoir

Lykos… moved to patent MDMA in late 2022, filing reveals

…another big ‘if’ is whether the company will even obtain FDA approval for its MDMA-assisted therapy at all… Specifically, Lykos’ patent application claims a composition comprising a salt or solvate of MDMA along with one or more excipients, where the average particle size in the composition is, at its broadest, between 50 and 400 microns,…

READ MORE
Biography/Memoir

After FDA setback, psychedelic drugmakers distance themselves from a pioneer

A resoundingly negative vote by an advisory committee to the Food and Drug Administration on Tuesday [6/5/24] – though not binding – has diminished the chances of the sponsor, Lykos Therapeutics, from winning full approval for MDMA to treat post-traumatic stress disorder, industry observers said. But biotech executives, investors and researchers said in interviews that…

READ MORE
Biography/Memoir

Colorado Senate passes bill that could ban social media users who post positively about drugs – including legal psychedelics

The measure’s language… …“severely handicaps the emergent psychedelic ecosystem at all levels to educate the public and gives broad powers to a state apparatus to take legal action against individuals for expressing their opinion online,” says Kevin Matthews, director of the campaign in Denver that made the city the first in the U.S. to decriminalize…

READ MORE
Biography/Memoir

Compass Pathways… resigned…

They were the first company to take all of the practical knowledge and lived wisdom from philanthropically funded researchers, pivot to for profit, and meanwhile convince the leader of the most loved/popular mdma non-profit to do the same. Now we have COMPASS + Lykos… Compass Pathways plc (Nasdaq: CMPS) (“Compass”), a biotechnology company… announced that…

READ MORE